US biotech MaxCyte chooses London for IPO
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings
EquityEquity IPOs

US biotech MaxCyte chooses London for IPO

Olivier Holmey
March 30, 2016 06:00 PM
Pharmaceutical 230x150

US biotech firm MaxCyte started trading on London’s junior stock exchange on Tuesday, after raising £10m from its initial public offering.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOsEquityUKUnited States
OH
Olivier Holmey
Gift this article